Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023, according to NHS data. It’s also the second-deadliest form of the ...

In this two-part series, we'll describe the PSA test-- how it's used, and how doctors perform next steps in the event of an abnormal reading. Our first post addresses PSA screening for prostate cancer ...

A federal panel’s controversial recommendation that healthy men older than 50 avoid a PSA-based prostate screening test is drawing scorn from some doctors. The U.S. Preventive Services Task Force, an ...

To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...

or on the link below. Prostate-specific antigen (PSA) is both a blessing and a curse for prostate cancer. It is a blessing because it makes prostate cancer one of the few cancers with a reliable serum ...

From AI-generated biopsy reports to new imaging techniques, these are the latest developments in advanced prostate cancer research that your doctor may be keeping tabs on. Much of managing advanced ...

Add Yahoo as a preferred source to see more of our stories on Google. Writer Nick Harding has a blood test at a GFCT prostate cancer screening event at the Nelson Club in Warwick - Andrew Fox A few ...

Patrick Shannon of Kenhorst was relishing a new phase of life — retirement from his careers in construction and security — when his primary care doctor called with unexpected news. Shannon’s recent ...

A new at-home saliva test could help identify men with a high risk of prostate cancer more accurately than blood tests, leading to earlier diagnosis and more successful treatment. Prostate cancer is ...

Thank you for signing up! Did you know with an ad-lite subscription to Burnley Express, you get 70% fewer ads while viewing ...

Landmark UK prostate cancer screening trial begins with first men tested - Trial will inform future population-wide prostate cancer screening programmes for men ...